Armen Aprikian
Director/Board Member at Nanostics, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| John Lewis | M | - |
Nanostics, Inc.
 Nanostics, Inc. Medical SpecialtiesHealth Technology Nanostics, Inc. specializes in the development and commercialization of novel, non-invasive diagnostic tests for cancer. It offers ClarityDx, is the accurate diagnostic test to diagnose aggressive prostate cancer, and is positioned to emerge as the diagnostic tool for prostate cancer. The company was founded by John Lewis, Catalina Vasquez, Desmond Pink and Robert Paproski in 2017 and is headquartered in Edmonton, Canada. | 7 years |
| Robert Paproski | M | - |
Nanostics, Inc.
Nanostics, Inc. Medical SpecialtiesHealth Technology Nanostics, Inc. specializes in the development and commercialization of novel, non-invasive diagnostic tests for cancer. It offers ClarityDx, is the accurate diagnostic test to diagnose aggressive prostate cancer, and is positioned to emerge as the diagnostic tool for prostate cancer. The company was founded by John Lewis, Catalina Vasquez, Desmond Pink and Robert Paproski in 2017 and is headquartered in Edmonton, Canada. | 7 years |
| Bert Vandal | M | 63 |
McGill University
| 18 years |
| John Edward Cleghorn | M | 82 |
McGill University
| - |
| Catalina Vasquez | F | - |
Nanostics, Inc.
Nanostics, Inc. Medical SpecialtiesHealth Technology Nanostics, Inc. specializes in the development and commercialization of novel, non-invasive diagnostic tests for cancer. It offers ClarityDx, is the accurate diagnostic test to diagnose aggressive prostate cancer, and is positioned to emerge as the diagnostic tool for prostate cancer. The company was founded by John Lewis, Catalina Vasquez, Desmond Pink and Robert Paproski in 2017 and is headquartered in Edmonton, Canada. | 7 years |
| Desmond Pink | M | - |
Nanostics, Inc.
Nanostics, Inc. Medical SpecialtiesHealth Technology Nanostics, Inc. specializes in the development and commercialization of novel, non-invasive diagnostic tests for cancer. It offers ClarityDx, is the accurate diagnostic test to diagnose aggressive prostate cancer, and is positioned to emerge as the diagnostic tool for prostate cancer. The company was founded by John Lewis, Catalina Vasquez, Desmond Pink and Robert Paproski in 2017 and is headquartered in Edmonton, Canada. | 7 years |
| Tullio Cedraschi | M | 85 |
McGill University
| - |
| Phillip Gold | M | 83 |
McGill University
| - |
| John W. Commissiong | M | 79 |
McGill University
| - |
| Guy Laliberté | M | - |
McGill University
| - |
| Marie-Josée Lamothe | F | 56 |
McGill University
| - |
| Michael Churchill-smith | M | - |
McGill University
| 37 years |
| Hartley S. Stern | M | - |
McGill University
| - |
| Joe Clark | M | - |
McGill University
| - |
| Mikihiro Yasuda | M | 53 |
McGill University
| 11 years |
| Nicola Walter Palmieri | M | 89 |
McGill University
| - |
| David Goltzman | M | - |
McGill University
| - |
| Sylvain Chemtob | M | - |
McGill University
| - |
| Hugh Scott | M | - |
McGill University
| - |
| Hyman M. Schipper | M | - |
McGill University
| - |
| Nicolas Matziorinis | M | - |
McGill University
| 36 years |
| Amit Bar-Or | M | - |
McGill University
| - |
| Elliot Lifson | M | - |
McGill University
| - |
| Jeannie L. Haggerty | M | - |
McGill University
| - |
| Viviane Yargeau | M | - |
McGill University
| 20 years |
| Joel Cohen | M | - |
McGill University
| - |
| Mark Ware | M | - |
McGill University
| 23 years |
| Aubrey Rankin | M | - |
Nanostics, Inc.
Nanostics, Inc. Medical SpecialtiesHealth Technology Nanostics, Inc. specializes in the development and commercialization of novel, non-invasive diagnostic tests for cancer. It offers ClarityDx, is the accurate diagnostic test to diagnose aggressive prostate cancer, and is positioned to emerge as the diagnostic tool for prostate cancer. The company was founded by John Lewis, Catalina Vasquez, Desmond Pink and Robert Paproski in 2017 and is headquartered in Edmonton, Canada. | 2 years |
| Jean-Francois Yale | M | - |
McGill University
| - |
| Sarkis Meterissian | M | 62 |
McGill University
| - |
| Michael DiGrappa | M | - |
McGill University
| - |
| Danny Ritter | M | - |
McGill University
| - |
| Tina Hobday | F | - |
McGill University
| - |
| Alvin Shrier | M | - |
McGill University
| - |
| Daniel Levitin | M | - |
McGill University
| - |
| Giovanna Santullo | F | - |
McGill University
| - |
| Paul Chipperton | M | - |
McGill University
| - |
| Shie Mannor | M | - |
McGill University
| - |
| Warren J. Gross | M | - |
McGill University
| - |
| Andrew Karaplis | M | - |
McGill University
| - |
| Jan Peeters | M | 72 |
McGill University
| 25 years |
| Samuel Minzberg | M | 67 |
McGill University
| - |
| Richard I. Levin | M | 75 |
McGill University
| 18 years |
| François Painchaud | M | 60 |
McGill University
| - |
| Thomas Kierans | M | 81 |
McGill University
| - |
| Gerald Sheff | M | - |
McGill University
| - |
| Manon R. Vennat | F | - |
McGill University
| - |
| Stephen Halperin | M | 74 |
McGill University
| - |
| Maryse Bertrand | F | 65 |
McGill University
| 8 years |
| James Jonathan Nelson | M | 76 |
McGill University
| - |
| Michael Boychuk | M | 68 |
McGill University
| - |
| Perry Miele | M | 64 |
McGill University
| - |
| Kenneth S. Atlas | M | - |
McGill University
| - |
| Tony Falco | M | - |
McGill University
| - |
| Emily Hamilton | M | - |
McGill University
| - |
| B. Cimler | M | 66 |
Nanostics, Inc.
Nanostics, Inc. Medical SpecialtiesHealth Technology Nanostics, Inc. specializes in the development and commercialization of novel, non-invasive diagnostic tests for cancer. It offers ClarityDx, is the accurate diagnostic test to diagnose aggressive prostate cancer, and is positioned to emerge as the diagnostic tool for prostate cancer. The company was founded by John Lewis, Catalina Vasquez, Desmond Pink and Robert Paproski in 2017 and is headquartered in Edmonton, Canada. | - |
| Xin Zhao | M | 63 |
McGill University
| 31 years |
| Peter D. Nesgos | M | - |
McGill University
| - |
| Pierre Matuszewski | M | - |
McGill University
| - |
| Melissa Sonberg | F | 64 |
McGill University
| 10 years |
| Samira Sakhia | F | 55 |
McGill University
| - |
| Ronald D. Guttmann | M | 87 |
McGill University
| - |
| Lawrence Hoffman | M | - |
McGill University
| - |
| C. Joseph Clark | M | - |
McGill University
| - |
| Martine Turcotte | F | 63 |
McGill University
| - |
| Francine Gervais | M | - |
McGill University
| - |
| Siegfried Hekimi | M | - |
McGill University
| - |
| Nathalie Bourque | F | - |
McGill University
| - |
| Gordon C. Shore | M | - |
McGill University
| - |
| François Gilbert | M | - |
McGill University
| - |
| Allan Pont | M | - |
McGill University
| - |
| Mike Schoenberger | M | - |
Nanostics, Inc.
Nanostics, Inc. Medical SpecialtiesHealth Technology Nanostics, Inc. specializes in the development and commercialization of novel, non-invasive diagnostic tests for cancer. It offers ClarityDx, is the accurate diagnostic test to diagnose aggressive prostate cancer, and is positioned to emerge as the diagnostic tool for prostate cancer. The company was founded by John Lewis, Catalina Vasquez, Desmond Pink and Robert Paproski in 2017 and is headquartered in Edmonton, Canada. | - |
Connections Chart
Multi-company connection
Statistics
| Country | Connections | % of total |
|---|---|---|
| Canada | 72 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Armen Aprikian
- Personal Network
